// App-Quantinova.ai

518 : Novel Genomic Structural Variations in Relapsed Childhood ETV6/RUNX1 (TEL/AML1) Acute Lymphoblastic Leukemias Identified by Next Generation Sequencing

Researchers

Presenter

  • Christoph Bartenhagen

Principal Investigators

  • Michael Gombert

  • Jochen Harbott

  • Martin Stanulla

  • Cornelia Eckert

  • Ralf Thiele

  • Martin Dugas

  • Arndt Borkhardt

  • Ute Fischer

  • Sebastian Ginzel

  • Pina Fanny Ida Krell

  • Peter Husemann

  • Cai Chen

  • Vera Binder

  • Jutta Bradtke

  • Andrea Teigler-Schlegel

  • Silja Roettgers

Medical Centers

  • Department of Medicine, University Medical Center Schleswig-Holstein, Kiel, Germany

  • Department of Pediatric Hematology and Oncology, University Giessen, Giessen, Germany

  • Department of Pediatric Oncology Hematology and clinical Immunology,University Hospital Duesseldorf, Dusseldorf, Germany

  • Department of Computer Science, University of Bonn-Rhine-Sieg, Bonn, Germany

  • Department of Pediatric Hematology and Oncology, Charite-University Hospital, Berlin, Campus Virchow Klinikum, Berlin, Germany

  • Institute of Medical Informatics, University of Muenster, Muenster, Germany

Locations

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • ETV6-RUNX1

Drug/Treatment

  • Lanthanum carbonate

  • Balofloxacin

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim